Repligen | 资产

股票价格
142.18
每天变化
2.52 1.80%
每月一次
-15.89%
每年
-8.89%
Q1 预测
137.82


金融业
股票价格
USD
资产
USD 2.92B
现金及等价物
USD 748.75M
销售成本
USD 88.29M
流动资产
USD 1.1B
流动负债
USD 131.14M
债务
USD 533.73M
EBIT
USD 16.81M
EBITDA
USD 35.93M
员工
1.78K
EPS每股收益
USD 0.46
股本和储备
USD 442.96M
销售毛利
USD 100.52M
债务利息支出
USD 5.41M
利息收入
USD 7.31M
贷款资金
USD 537.93M
市值
USD 7.79B
净收入
USD 14.91M
营业费用
USD 176.13M
营业利润
USD 12.68M
普通股股本
USD 56.28M
PE价格收益
USD 140.18
税前利润
USD 17.11M
销售收入
USD 189M
销售和管理费用
USD 73.66M
股票
USD 160.32M
贸易债权人
USD 29.43M
应收帐款人
USD 148.97M


资产 更改 日
Agilent USD 12.73B 501M 2025-09
Align Technology USD 6.23B 141K 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Bruker USD 6.43B 95.1M 2025-09
Charles River Laboratories USD 7.51B 46.73M 2025-09
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.65B 416M 2025-09
Exact Sciences USD 5.9B 102.64M 2025-09
General Electric Aerospace USD 130.17B 1.93B 2025-12
Henry Schein USD 11.1B 191M 2025-09
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Repligen USD 2.92B 22.08M 2025-09
Revvity USD 12.14B 223.84M 2025-09
Standard Biotools USD 539.64M 17.32M 2025-09
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Waters USD 4.86B 144.49M 2025-09
West Pharmaceutical Services USD 4.11B 153M 2025-09


Repligen 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.